Edition:
United Kingdom

bluebird bio Inc (BLUE.OQ)

BLUE.OQ on NASDAQ Stock Exchange Global Select Market

153.58USD
20 Mar 2019
Change (% chg)

$-2.52 (-1.61%)
Prev Close
$156.10
Open
$155.18
Day's High
$156.89
Day's Low
$151.80
Volume
127,735
Avg. Vol
210,101
52-wk High
$199.35
52-wk Low
$87.64

Chart for

About

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $5,824.04
Shares Outstanding(Mil.): 45.59
Dividend: --
Yield (%): --

Financials

  BLUE.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -7.36 -- --
ROI: -25.26 8.89 13.82
ROE: -29.40 10.00 15.25

Earnings vs. Estimates